MT-4129 free base · Synonyms: Lorundrostat
Lorundrostat is an orally active aldosterone synthase inhibitor.
For research use only. Not for human or veterinary use.
Target
Cytochrome P450
Research area
Cardiovascular Disease
Purity >98%
Stock Inquire
MT-4129 structure
CAS No.: 1820940-17-7
Pack sizes & pricing
| Size | Price | SKU | Stock | |
|---|---|---|---|---|
| 50 mg | USD 480.00 | BP-02162-50mg | In stock | Get quote |
| 100 mg | USD 760.00 | BP-02162-100mg | In stock | Get quote |
| 250 mg | USD 1,500.00 | BP-02162-250mg | In stock | Get quote |
| 500 mg | USD 2,400.00 | BP-02162-500mg | In stock | Get quote |
| 1 g | USD 3,800.00 | BP-02162-1g | In stock | Get quote |
Need another size or custom synthesis? Request a quote.
Description
Lorundrostat (MT-4129) is an orally active aldosterone synthase inhibitor. Lorundrostat can be used in studies of high blood pressure.
Biological activity
In Vitro Lorundrostat selectively inhibits human CYP11B2 (IC50 = 9 nM), reduces plasma aldosterone and systolic blood pressure, and can be used in research of obesity- or renin-induced hypertension.
Identifiers
- SMILES
-
CC(N[C@@H](CC1)CC[C@H]1NC(CN2CCN(CC2)C3=NN=CC(C4=CC=C(C=C4)C)=N3)=O)=O - InChIKey
-
YHGVDZULVMINCJ-MEMLXQNLSA-N
Specifications
- MW (average)
- 451.5645
- Formula
- C24H33N7O2
- CAS No.
- 1820940-17-7
- Physical state
- Solid
- Color
- light yellow to yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20°C, 3 years , 4°C, 2 years ; In solvent -20°C, 1 month
Solubility
Soluble in DMSO : 33.33 mg/mL
Documents
References
[1]. International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 2, 2022.
[2]. Laffin LJ, et al. Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial. JAMA. 2023 Sep 26;330(12):1140-1150
[3]. Hideki K, et al., Novel disubstituted 1,2,4-triazine compounds. WO2015163427.
Same research area
Search Cardiovascular Disease- BP-00840 Lp(a)-IN-5 free base · >98%
- BP-01911 Praliciguat free base · >98%
- BP-01912 Olinciguat free base · >98%
- BP-01915 Cipepofol free base · >98%
- BP-01919 Rodatristat ethyl free base · 98+%
- BP-01939 Ingliforib free base · >98%
- BP-01940 Vicadrostat free base · >98%
- BP-02138 GSK5182 free base · >98%